Learn more about the CTS Pilot Awards Program designed to support innovative, early-stage research.
Atul Varadhachary of Fannin covers the development of a hybrid model to commercialize academic pharmaceutical/biotechnology research.
Jin Wang of Baylor College of Medicine covers the development of targeted protein degraders that can be applied to overcome resistance in targeted cancer therapies and immunotherapies.
Colin Haile will discuss the development of an anti-fentanyl vaccine that blocks the drug’s effects, offering a new approach to treating opioid use disorder and overdose prevention.
DOR also hosts town halls and special sessions with its offices, other University representatives, and external partners. Recent events included a joint presentation by Animal Care Operations and the Research Integrity and Oversight offices, UH Federal Relations, and agency updates from the University’s federal research consultant, McAllister & Quinn.